$OPGN
OPGEN INC

2018 Q1 Form 10-K Financial Statement

#000156459018007151 Filed on March 29, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 2016 Q4
Revenue $846.2K $3.211M $1.010M
YoY Change 9.65% -20.24% -24.06%
Cost Of Revenue $168.6K $520.3K $490.0K
YoY Change 68.16% -17.58% -23.44%
Gross Profit $677.7K $2.691M $520.0K
YoY Change 0.91% -20.73% -24.64%
Gross Profit Margin 80.08% 83.8% 51.49%
Selling, General & Admin $2.120M $9.460M $2.890M
YoY Change -31.04% -22.02% -20.6%
% of Gross Profit 312.88% 351.6% 555.77%
Research & Development $1.230M $6.883M $2.330M
YoY Change -42.03% -20.08% 3.1%
% of Gross Profit 181.57% 255.82% 448.08%
Depreciation & Amortization $156.3K $669.1K $170.0K
YoY Change -2.21% 1.99% -26.09%
% of Gross Profit 23.07% 24.87% 32.69%
Operating Expenses $3.351M $16.34M $5.230M
YoY Change -35.53% -21.22% -5.08%
Operating Profit -$3.016M -$15.27M -$4.710M
YoY Change -39.08% -19.69% -2.28%
Interest Expense $57.85K $233.5K -$50.00K
YoY Change 93.83% 62.89% 25.0%
% of Operating Profit
Other Income/Expense, Net -$32.20K -$153.5K
YoY Change 18.37% -2.48%
Pretax Income -$3.048M -$15.42M -$4.760M
YoY Change -38.77% -19.55% -2.06%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.048M -$15.42M -$4.760M
YoY Change -38.77% -19.55% 0.63%
Net Earnings / Revenue -360.2% -480.2% -471.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$15.25M -$192.8M -$95.20M
COMMON SHARES
Basic Shares Outstanding 5.290M 21.72M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.29M $1.850M $4.120M
YoY Change 516.17% -55.1% -47.25%
Cash & Equivalents $10.29M $1.850M $4.117M
Short-Term Investments
Other Short-Term Assets $240.0K $310.0K $330.0K
YoY Change -11.11% -6.06% -42.11%
Inventory $510.0K $530.0K $692.4K
Prepaid Expenses
Receivables $590.0K $810.0K $542.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.63M $3.500M $5.682M
YoY Change 292.84% -38.38% -42.52%
LONG-TERM ASSETS
Property, Plant & Equipment $830.0K $840.0K $800.7K
YoY Change 11.63% 5.0% -25.49%
Goodwill $600.8K
YoY Change -5.76%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $270.0K $330.0K $279.8K
YoY Change -9.42% 17.86% 3.49%
Total Long-Term Assets $2.980M $3.120M $3.302M
YoY Change -6.77% -5.45% -14.7%
TOTAL ASSETS
Total Short-Term Assets $11.63M $3.500M $5.682M
Total Long-Term Assets $2.980M $3.120M $3.302M
Total Assets $14.61M $6.620M $8.984M
YoY Change 137.29% -26.28% -34.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.440M $1.690M $2.233M
YoY Change -28.61% -24.22% -2.33%
Accrued Expenses $2.100M $1.910M $1.215M
YoY Change 137.8% 6.7% 32.05%
Deferred Revenue
YoY Change
Short-Term Debt $980.0K $1.010M $1.024M
YoY Change -1.9% -0.98%
Long-Term Debt Due $190.0K $150.0K $180.0K
YoY Change 11.76% -16.67% -28.0%
Total Short-Term Liabilities $4.740M $4.790M $5.272M
YoY Change -7.44% -9.11% 14.86%
LONG-TERM LIABILITIES
Long-Term Debt $310.0K $130.0K $150.0K
YoY Change 181.82% -13.33% -88.64%
Other Long-Term Liabilities $260.0K $300.0K $400.0K
YoY Change -29.73% -25.0% 14.29%
Total Long-Term Liabilities $570.0K $430.0K $550.0K
YoY Change 18.75% -21.82% -67.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.740M $4.790M $5.272M
Total Long-Term Liabilities $570.0K $430.0K $550.0K
Total Liabilities $5.310M $5.220M $5.817M
YoY Change -5.23% -10.31% -7.16%
SHAREHOLDERS EQUITY
Retained Earnings -$133.3M
YoY Change 16.79%
Common Stock $10.12K
YoY Change -91.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.300M $1.400M $3.167M
YoY Change
Total Liabilities & Shareholders Equity $14.61M $6.620M $8.984M
YoY Change 137.29% -26.28% -34.69%

Cashflow Statement

Concept 2018 Q1 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$3.048M -$15.42M -$4.760M
YoY Change -38.77% -19.55% 0.63%
Depreciation, Depletion And Amortization $156.3K $669.1K $170.0K
YoY Change -2.21% 1.99% -26.09%
Cash From Operating Activities -$2.232M -$14.30M -$4.380M
YoY Change -49.95% -17.08% 36.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $277.0K -$30.00K
YoY Change -100.0% 124.23% -70.0%
Acquisitions
YoY Change
Other Investing Activities $10.00K $0.00
YoY Change
Cash From Investing Activities $10.44K -$277.0K -$30.00K
YoY Change -134.8% 130.79% -70.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $3.809M
YoY Change -100.0% -13.55%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.62M 12.35M 4.260M
YoY Change 420.72% -9.6% -7200.0%
NET CHANGE
Cash From Operating Activities -2.232M -14.30M -4.380M
Cash From Investing Activities 10.44K -277.0K -30.00K
Cash From Financing Activities 10.62M 12.35M 4.260M
Net Change In Cash 8.388M -2.270M -150.0K
YoY Change -442.77% -38.81% -95.55%
FREE CASH FLOW
Cash From Operating Activities -$2.232M -$14.30M -$4.380M
Capital Expenditures $0.00 $277.0K -$30.00K
Free Cash Flow -$2.232M -$14.58M -$4.350M
YoY Change -50.26% -16.07% 39.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4117324
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
542420
CY2016Q4 us-gaap Inventory Net
InventoryNet
692368
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
24442
CY2017 opgn Laboratory Services Revenue
LaboratoryServicesRevenue
41960
CY2017 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q2 dei Entity Public Float
EntityPublicFloat
11102412000000
CY2017 opgn Collaborations Revenue
CollaborationsRevenue
397178
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
835537
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1353182
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
328601
CY2017Q4 us-gaap Assets
Assets
6619914
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1691712
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
746924
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
809540
CY2017Q4 us-gaap Inventory Net
InventoryNet
533425
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
311644
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
154839
CY2017Q4 us-gaap Assets Current
AssetsCurrent
3501780
CY2017Q4 us-gaap Goodwill
Goodwill
600814
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1160714
CY2017Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1010961
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4789592
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
290719
CY2017Q4 opgn Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
8453
CY2016Q4 opgn Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
0
CY2017Q4 us-gaap Liabilities
Liabilities
5218917
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
136442302
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6176
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25900
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
22653
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
10122
CY2016Q4 opgn Long Term Capital Lease Obligation And Other Noncurrent Liabilities
LongTermCapitalLeaseObligationAndOtherNoncurrentLiabilities
146543
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Liabilities
Liabilities
5816564
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-148710427
CY2017Q4 opgn Long Term Capital Lease Obligation And Other Noncurrent Liabilities
LongTermCapitalLeaseObligationAndOtherNoncurrentLiabilities
130153
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
150114671
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1012171
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2265320
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2265320
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1012171
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
2771869
CY2016 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
3524178
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3167481
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6619914
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133291119
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1400997
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8984045
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
800723
CY2016Q4 us-gaap Goodwill
Goodwill
600814
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1620998
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
279752
CY2016Q4 us-gaap Assets
Assets
8984045
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2232563
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
578480
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1215283
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
37397
CY2016Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1023815
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
184399
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5271937
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
398084
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23771
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
CY2017 dei Trading Symbol
TradingSymbol
OPGN
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5289919
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1847171
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
329646
CY2016Q4 us-gaap Assets Current
AssetsCurrent
5681758
CY2017 us-gaap Revenues
Revenues
3211007
CY2017 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1612838
CY2017 us-gaap Cost Of Services
CostOfServices
520338
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6883293
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6692659
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2767670
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
18476798
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
23035022
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-15265791
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-19009337
CY2017 opgn Interest And Other Income Expense
InterestAndOtherIncomeExpense
-87255
CY2016 opgn Interest And Other Income Expense
InterestAndOtherIncomeExpense
-5967
CY2017 us-gaap Interest Expense
InterestExpense
233505
CY2016 us-gaap Interest Expense
InterestExpense
143347
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
23179
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8102
CY2017 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
144064
CY2016 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
0
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-153517
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-157416
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15419308
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19166753
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-15419308
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-19166753
CY2017 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
CY2016 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
332550
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15419308
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19499303
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.80
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-27.59
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1573769
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
706702
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32076
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
7235
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15451384
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19159518
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
7491046
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
945461
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
7235
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8180
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
911398
CY2017 opgn Stock Issued During Period Value Legal Settlement
StockIssuedDuringPeriodValueLegalSettlement
109999
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
23245
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-32076
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
669088
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
656047
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2016 us-gaap Cost Of Services
CostOfServices
631333
CY2016 opgn Laboratory Services Revenue
LaboratoryServicesRevenue
228904
CY2016 opgn Collaborations Revenue
CollaborationsRevenue
272603
CY2016 us-gaap Revenues
Revenues
4025685
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1658571
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8613236
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6602608
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5529274
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6309
CY2016 opgn Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
0
CY2017 us-gaap Accretion Expense
AccretionExpense
185294
CY2016 us-gaap Accretion Expense
AccretionExpense
4527
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
911398
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
945461
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
113465
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-144064
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2017 opgn Unamortized Discount On Bridge Loan At Repayment
UnamortizedDiscountOnBridgeLoanAtRepayment
85932
CY2016 opgn Unamortized Discount On Bridge Loan At Repayment
UnamortizedDiscountOnBridgeLoanAtRepayment
0
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
260471
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-136226
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-161027
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20179
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
315688
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-263882
CY2017 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-563357
CY2016 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-53229
CY2017 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
399224
CY2016 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-163223
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-12955
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-13528
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14303880
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17250637
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
276950
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
123514
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-276950
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-123514
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3808836
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4405973
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
204895
CY2017 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2016 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9460749
CY2017 opgn Net Proceeds From Issuance Of Common Stock And Warrants
NetProceedsFromIssuanceOfCommonStockAndWarrants
8754882
CY2016 opgn Net Proceeds From Issuance Of Common Stock And Warrants
NetProceedsFromIssuanceOfCommonStockAndWarrants
0
CY2017 opgn Proceeds From Stock Options And Warrant Exercises
ProceedsFromStockOptionsAndWarrantExercises
76537
CY2016 opgn Proceeds From Stock Options And Warrant Exercises
ProceedsFromStockOptionsAndWarrantExercises
23771
CY2017 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
1168222
CY2016 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0
CY2017 us-gaap Repayments Of Debt
RepaymentsOfDebt
1255198
CY2016 us-gaap Repayments Of Debt
RepaymentsOfDebt
178997
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
205085
CY2016 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
251701
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
12348194
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
13664690
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-37517
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
12565
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2270153
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3696896
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7814220
CY2017 us-gaap Interest Paid
InterestPaid
48211
CY2016 us-gaap Interest Paid
InterestPaid
58564
CY2017 opgn Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
48398
CY2017 us-gaap Stock Issued1
StockIssued1
133245
CY2016 us-gaap Stock Issued1
StockIssued1
0
CY2017 opgn Issuance Of Placement Agent Warrant
IssuanceOfPlacementAgentWarrant
93677
CY2016 opgn Issuance Of Placement Agent Warrant
IssuanceOfPlacementAgentWarrant
0
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, share-based compensation, allowances for doubtful accounts and inventory obsolescence, valuation of derivative financial instruments, beneficial conversion features of convertible debt, deferred tax assets and liabilities and related valuation allowance, and depreciation and amortization and estimated useful lives of long-lived assets. Actual results could differ from those estimates.</p></div>
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
243380
CY2016Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
243380
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
31278
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
26716
CY2016 opgn Number Of Individual Customers Accounting For More Than Ten Percent Of Revenue
NumberOfIndividualCustomersAccountingForMoreThanTenPercentOfRevenue
0
CY2017Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
360134
CY2016Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
479479
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
51233
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
27422
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
122058
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
185467
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
155507
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
704516
CY2017 us-gaap Depreciation
Depreciation
401272
CY2016 us-gaap Depreciation
Depreciation
388231
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7044821
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6608735
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6209284
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5808012
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2013000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
12330
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
139395
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
139395
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
63365
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
65.00
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
35.25
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.00
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
99.75
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
212.25
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.00
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
17.58
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
659818
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2013000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
392002
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
267816
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
267816
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
267816
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
267816
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
267816
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
267816
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
165117
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
116801
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2016Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9500000
CY2017 opgn Convertible Preferred Stock Beneficial Conversion Feature Recognized As Deemed Dividend
ConvertiblePreferredStockBeneficialConversionFeatureRecognizedAsDeemedDividend
332550
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
911398
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
945461
CY2017 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1300000
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P8Y3M18D
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
86431
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2660
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
22868
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
343
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
119106
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58324
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1167
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
24538
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.01
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
36.31
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
83.49
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.16
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
31.16
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.73
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M6D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y3M18D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y8M12D
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1575646
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
79406
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58546
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
663298
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11256
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
37339
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
37339
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
33575
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2086843
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1088978
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.018
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.012
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.023
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.022
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.442
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.420
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.530
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.498
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1495008
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
420262
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
49251408
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
63520548
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49251408
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
63520548
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
46326407
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
60357220
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2559479
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2559479
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
345088
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
448534
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
45338
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
269708
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
71756
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
117629
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
247093
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
333126
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49595161
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
64085696
CY2017Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
343753
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
565148
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.068
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.065
CY2017 opgn Effective Income Tax Rate Reconciliation Tax Reform Impact
EffectiveIncomeTaxRateReconciliationTaxReformImpact
-1.345
CY2016 opgn Effective Income Tax Rate Reconciliation Tax Reform Impact
EffectiveIncomeTaxRateReconciliationTaxReformImpact
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.930
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.373
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.007
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.032
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 opgn Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Asset Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpenseBenefit
14600000
CY2017 opgn Tax Cuts And Jobs Act Of2017 Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ProvisionalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
During the second quarter of 2015, the Company extended the term of its Gaithersburg, Maryland office lease, effective May 7, 2015, through January 31, 2021, with one additional five-year renewal at the Company’s election. The Company is responsible for all utilities, repairs, insurance, and taxes under this operating lease. Effective July 1, 2015, the Company further modified its lease agreement to add additional leased space to its headquarters. Additionally, the Company leases office space in Denmark; this lease is currently on a month-to-month basis.
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
949244
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000726
CY2017 us-gaap Description Of Lessee Leasing Arrangements Capital Leases
DescriptionOfLesseeLeasingArrangementsCapitalLeases
The Company leases computer equipment, office furniture, and equipment under various capital leases. The leases expire at various dates through 2021. The leases require monthly principal and interest payments.
CY2017 opgn Capital Leases Expiration Date Description
CapitalLeasesExpirationDateDescription
The leases expire at various dates through 2021.
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
177464
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
85393
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
56981
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
1773
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
321611
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
36619
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
284992
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
130153
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1041323
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1054374
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1072748
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
482058
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
35647
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3686150
CY2017Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1218787
CY2017Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1139767
CY2017Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1129729
CY2017Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
483830
CY2017Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
35647
CY2017Q4 us-gaap Contractual Obligation
ContractualObligation
4007760
CY2017Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
454471
CY2016Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
270808
CY2017Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
485461
CY2016Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
379161
CY2017 opgn One Time Restructuring Benefits
OneTimeRestructuringBenefits
121000
CY2017 opgn Retention Expense Cost Incurred
RetentionExpenseCostIncurred
68000
CY2017 opgn Designated Service Period Of Employees Description
DesignatedServicePeriodOfEmployeesDescription
The service periods ended in December 2017
CY2017 opgn Royalty Income Expense
RoyaltyIncomeExpense
-257186
CY2016 opgn Royalty Income Expense
RoyaltyIncomeExpense
-290491
CY2017Q4 opgn Future Minimum Royalty Payments Due
FutureMinimumRoyaltyPaymentsDue
250000

Files In Submission

Name View Source Status
0001564590-18-007151-index-headers.html Edgar Link pending
0001564590-18-007151-index.html Edgar Link pending
0001564590-18-007151.txt Edgar Link pending
0001564590-18-007151-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018032921004711936650.jpg Edgar Link pending
g2018032921004772936651.jpg Edgar Link pending
g2018032921004779236652.jpg Edgar Link pending
opgn-10k_20171231.htm Edgar Link pending
opgn-20171231.xml Edgar Link completed
opgn-20171231.xsd Edgar Link pending
opgn-20171231_cal.xml Edgar Link unprocessable
opgn-20171231_def.xml Edgar Link unprocessable
opgn-20171231_lab.xml Edgar Link unprocessable
opgn-20171231_pre.xml Edgar Link unprocessable
opgn-ex104_411.htm Edgar Link pending
opgn-ex211_11.htm Edgar Link pending
opgn-ex231_7.htm Edgar Link pending
opgn-ex311_14.htm Edgar Link pending
opgn-ex312_15.htm Edgar Link pending
opgn-ex321_12.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending